Oncology Market Reports
Download in-depth intelligence on global cancer trends, emerging therapies, research markets, and investment landscapes
Our expert-curated oncology market reports provide comprehensive insights into global cancer trends, research activity, clinical trial density, treatment adoption, and investment patterns. These reports are designed for hospitals, research institutions, pharma partners, biotech startups, and investors seeking a strategic overview of the oncology landscape.
What's Inside:
- Worldwide cancer incidence projections
- Emerging therapy classes
- Geographic research hotspots
- Market expansion forecasts through 2030
- Top oncology investment trends
- Pipeline analysis by therapeutic area
Best For:
Hospitals • Investors • Pharma Strategy Teams
What's Inside:
- Phase I/II/III trials by region
- Top 20 trial sponsors
- Biomarker-aligned trials
- Asia-Pacific trial acceleration
- Pediatric oncology trial trends
- Decentralized & hybrid trials
Best For:
Clinical operations • Research institutions • CROs
What's Inside:
- EGFR, KRAS, HER2, NTRK, BRCA trends
- Top drug approvals by biomarker
- How precision medicine adoption is shifting globally
- Biomarker-specific trial volume
- Molecular diagnostics market outlook
Best For:
Oncologists • Diagnostics companies • Researchers
What's Inside:
- CAR-T therapy pipelines
- Checkpoint inhibitor growth
- Next-generation cell engineering
- New targets & mechanisms
- Key biotech innovators
- Market size forecast (2025–2032)
Best For:
Pharma • Biotech • Cell therapy manufacturers
What's Inside:
- Global radiopharma trial density
- Lutetium-177 and Actinium-225 pipeline
- Top radiopharmaceutical companies
- Nuclear medicine investment trends
- Regional adoption patterns
- Regulatory barriers
Best For:
Nuclear medicine • Pharma • Imaging Centers
What's Inside:
- AI pathology maturity index
- Regulatory approvals for imaging AI
- Multi-omics data platforms
- Clinical decision-support platforms
- Growth of digital oncology globally
- Top 20 AI oncology startups
Best For:
Health-tech investors • Hospitals • AI companies
Deep-dive market intelligence for specific countries, including trial volume, cancer incidence, funding programs, key institutions, research strengths, and market opportunities.
Each Report Includes:
- Clinical trial volume & trends
- National cancer incidence data
- Government funding programs
- Leading research institutions
- Country-specific research strengths
- Market entry opportunities